Supply of Srph153042-Coronary Drug Eluting Stents With 1 Stent On Cobalt Chromi Um Alloy Or Platinum Chromium Alloy. 2 Stent With Coating Of Polymer Carrier For Active Drug Sirolimus, Everolimus Or Zotarolimus Shown To Be Effective In Preven Ting Neo-Intimal Hyperplasia 3 Stent Diameter Should Be From 2.5Mm To 4Mm . The Le Ngth Of The Stent Should Be 12 To 48Mm . 4 The Strut Thickness Should Be 91 Micron Or Less. 5 Stent Delivery System Should Be Monorail Single Operator Exchange Or Rapid Exchange. 6 Stent Should Be Compatible With 5Fr Guiding Catheter 7 Stent D Esign Should Be Open Cell Type. 8 Stent Should Be Approved By Dcgi. The Copy Of Dc Gi Approval Should Be Enclosed In The Tender Bid / Offer. 9 The Long Term Efficacy And Safety Of The Stent, The Rates Of In-Stent Restenosis Isr And In-Situ Thrombosi S Ist Should Be Documented / Published In Peer Reviewed Scientific Journals. 10The Manufacturer/Supplier Should Submit Proof Of Supply Of The Stent To A Major Gov Ernment Institute.Bis Standards For The Drug Eluting Stent Are Not Available Refe Rence : Bis Catalogue Unit: No.
Supply of 12 Drug Delivery System Q3 Pac Only
Supply of Drug Delivery System Q3 Pac Only
